There are several questions surrounding Monkeypox in the East TN and Southeastern Kentucky region. Below is information to answer questions.
- Worldwide, there have been no reports of transmission of monkeypox virus through blood transfusion and the risk of transfusion-transmission remains theoretical.
- Routine measures used to determine blood donor eligibility prevent individuals with symptomatic infections from donating blood.
- Given the robustness of the existing safeguards for blood safety FDA does not recommend that blood establishments ask donors additional, specific questions about possible exposure to the monkeypox virus.
- FDA does not recommend using laboratory diagnostic tests to screen blood donors for the monkeypox virus.
- FDA will continue to monitor cases of monkeypox in the U.S. and worldwide and the available information about the potential risk of transfusion-transmitted monkeypox virus.
There is no deferral after receipt of the monkeypox vaccine. If a smallpox vaccination is given in lieu of a monkey pox vaccine, donor deferral may be required; consult with MEDIC staff.
Click here for the CDC information page on Monkeypox.
Click here for FDA information.
If you have further questions, please call us at 865-524-3074 or email us at firstname.lastname@example.org.